Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease
Clinical trial NCT02931305 · UNKNOWN
Trial details
- NCT number
- NCT02931305
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.